MOH
Income statement / Annual
Last year (2025), Molina Healthcare Inc's total revenue was $45.43 B,
an increase of 11.75% from the previous year.
In 2025, Molina Healthcare Inc's net income was $472.00 M.
See Molina Healthcare Inc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$45.43 B |
$40.65 B |
$34.07 B |
$31.97 B |
$27.77 B |
$19.42 B |
$16.83 B |
$18.89 B |
$19.88 B |
$17.71 B |
| Cost of Revenue |
$40.81 B
|
$35.91 B
|
$29.74 B
|
$28.05 B
|
$24.49 B
|
$16.75 B
|
$14.39 B
|
$16.27 B
|
$18.00 B
|
$15.94 B
|
| Gross Profit |
$4.61 B
|
$4.74 B
|
$4.33 B
|
$3.93 B
|
$3.28 B
|
$2.68 B
|
$2.44 B
|
$2.62 B
|
$1.88 B
|
$1.77 B
|
| Gross Profit Ratio |
0.1
|
0.12
|
0.13
|
0.12
|
0.12
|
0.14
|
0.14
|
0.14
|
0.09
|
0.1
|
| Research and Development Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$3.01 B
|
$2.74 B
|
$2.46 B
|
$2.31 B
|
$2.07 B
|
$1.48 B
|
$1.30 B
|
$1.33 B
|
$1.59 B
|
$1.39 B
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$3.01 B
|
$2.74 B
|
$2.46 B
|
$2.31 B
|
$2.07 B
|
$1.48 B
|
$1.30 B
|
$1.33 B
|
$1.59 B
|
$1.39 B
|
| Other Expenses |
$817.00 M
|
$286.00 M
|
$299.00 M
|
$442.00 M
|
$192.00 M
|
$119.00 M
|
$89.00 M
|
$15.68 B
|
$18.35 B
|
$139.00 M
|
| Operating Expenses |
$3.83 B
|
$3.03 B
|
$2.76 B
|
$2.75 B
|
$2.26 B
|
$1.60 B
|
$1.39 B
|
$17.01 B
|
$19.95 B
|
$1.53 B
|
| Cost And Expenses |
$44.64 B
|
$38.94 B
|
$32.50 B
|
$30.80 B
|
$26.75 B
|
$18.35 B
|
$15.78 B
|
$17.70 B
|
$20.44 B
|
$17.47 B
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$194.00 M
|
$118.00 M
|
$109.00 M
|
$110.00 M
|
$120.00 M
|
$102.00 M
|
$87.00 M
|
$115.00 M
|
$118.00 M
|
$101.00 M
|
| Depreciation & Amortization |
$213.00 M
|
$186.00 M
|
$171.00 M
|
$176.00 M
|
$131.00 M
|
$88.00 M
|
$89.00 M
|
$127.00 M
|
$178.00 M
|
$182.00 M
|
| EBITDA |
$996.00 M |
$1.89 B |
$1.74 B |
$1.35 B |
$1.13 B |
$1.15 B |
$1.15 B |
$1.24 B |
-$316.00 M |
$488.00 M |
| EBITDA Ratio |
0.02
|
0.05
|
0.05
|
0.04
|
0.04
|
0.06
|
0.07
|
0.07
|
-0.02
|
0.03
|
| Operating Income Ratio |
0.02
|
0.04
|
0.05
|
0.04
|
0.04
|
0.06
|
0.06
|
0.06
|
-0.03
|
0.02
|
| Total Other Income/Expenses Net |
-$194.00 M
|
-$118.00 M
|
-$109.00 M
|
-$110.00 M
|
-$145.00 M
|
-$117.00 M
|
-$72.00 M
|
-$132.00 M
|
-$57.00 M
|
-$101.00 M
|
| Income Before Tax |
$589.00 M
|
$1.59 B
|
$1.46 B
|
$1.06 B
|
$875.00 M
|
$961.00 M
|
$972.00 M
|
$999.00 M
|
-$612.00 M
|
$137.00 M
|
| Income Before Tax Ratio |
0.01
|
0.04
|
0.04
|
0.03
|
0.03
|
0.05
|
0.06
|
0.05
|
-0.03
|
0.01
|
| Income Tax Expense |
$117.00 M
|
$410.00 M
|
$373.00 M
|
$271.00 M
|
$216.00 M
|
$288.00 M
|
$235.00 M
|
$292.00 M
|
-$100.00 M
|
$129.00 M
|
| Net Income |
$472.00 M
|
$1.18 B
|
$1.09 B
|
$792.00 M
|
$659.00 M
|
$673.00 M
|
$737.00 M
|
$707.00 M
|
-$512.00 M
|
$8.00 M
|
| Net Income Ratio |
0.01
|
0.03
|
0.03
|
0.02
|
0.02
|
0.03
|
0.04
|
0.04
|
-0.03
|
0
|
| EPS |
8.93 |
20.52 |
18.71 |
13.7 |
11.4 |
11.41 |
11.85 |
10.61 |
-9.14 |
0.93 |
| EPS Diluted |
8.92 |
20.42 |
18.78 |
13.54 |
11.25 |
11.24 |
11.48 |
10.55 |
-9.14 |
0.92 |
| Weighted Average Shares Out |
$50.79 M
|
$57.40 M
|
$58.10 M
|
$57.80 M
|
$57.80 M
|
$59.00 M
|
$62.20 M
|
$66.64 M
|
$56.00 M
|
$55.00 M
|
| Weighted Average Shares Out Diluted |
$50.79 M
|
$57.70 M
|
$58.10 M
|
$58.50 M
|
$58.60 M
|
$59.90 M
|
$64.20 M
|
$67.00 M
|
$56.00 M
|
$56.00 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
